Association between ACE polymorphism and risk of IgA nephropathy: A meta-analysis

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 12, Issue 3, 2011, Pages 215-223

  Qin, Yuan Han ^a   Zhou, Tian Biao ^a   Su, Li Na ^a   Lei, Feng Ying ^a   Huang, Wei Fang ^a   Zhao, Yan Jun ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme; gene insertion deletion (I D); immunoglobulin A nephropathy; meta analysis; polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; ASIAN; CAUCASIAN; DISEASE COURSE; ETHNICITY; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; META ANALYSIS; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS, IGA; HUMANS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROTEINURIA; RISK FACTORS;

EID: 80052372943     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320310391835     Document Type: Article

References (44)

1. Roufosse CA and Cook HT Pathological predictors of prognosis in immunoglobulin A nephropathy: a review. Curr Opin Nephrol Hypertens 2009 ; 18: 212-219.
2. Yoshikawa N., Nakanishi K., Ishikura K., et al. Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study. Pediatr Nephrol 2008 ; 23: 757-763.
3. Narita I., Goto S., Saito N., et al. Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients. Hypertension 2003 ; 42: 304-309. (Pubitemid 37093477)
4. Bell CG, Meyre D., Petretto E., et al. No contribution of angiotensin-converting enzyme (ACE) gene variants to severe obesity: a model for comprehensive case/control and quantitative cladistic analysis of ACE in human diseases. Eur J Hum Genet 2007 ; 15: 320-327.
5. Kostic M., Stankovic A., Zivkovic M., et al. ACE and AT1 receptor gene polymorphisms and renal scarring in urinary bladder dysfunction. Pediatr Nephrol 2004 ; 19: 853-857. (Pubitemid 39144766)
6. Bantis C., Ivens K., Kreusser W., et al. Influence of genetic polymorphisms of the renin-angiotensin system on IgA nephropathy. Am J Nephrol 2004 ; 24: 258-267. (Pubitemid 38456637)
7. Szelestei T., Bahring S., Kovacs T., et al. Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy. Am J Kidney Dis 2000 ; 36: 468-473.
8. Hunley TE, Julian BA, Phillips JR, et al. Angiotensin-converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996 ; 49: 571-577. (Pubitemid 26051837)
9. Suzuki H., Sakuma Y., Kanesaki Y., et al. Close relationship of plasminogen activator inhibitor-1 4G/5G polymorphism and progression of IgA nephropathy. Clin Nephrol 2004 ; 62: 173-179. (Pubitemid 39236620)
10. Yoon HJ, Kim H., Kim HL, et al. Interdependent effect of angiotensin-converting enzyme and platelet-activating factor acetylhydrolase gene polymorphisms on the progression of immunoglobulin A nephropathy. Clin Genet 2002 ; 62: 128-134. (Pubitemid 36372712)
11. Fukushima T., Nomura S., Kawai S. and Osawa G. ACE genotype and progression of IgA nephropathy. Lancet 1995 ; 346: 571.
12. Chen X., Liu S., Ye Y. and Xu Q. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with the clinico-pathological manifestations in immunoglobulin A nephropathy patients. Chin Med J (Engl) 1997 ; 110: 526-529. (Pubitemid 127510188)
13. Liu SW, Chen XM, Ding R. and Lu Y. Association of ACE gene insertion/deletion polymorphism with IgA nephropathy. Chin J Lab Diagn 2005 ; 5: 751 [In Chinese].
14. Harden PN, Geddes C., Rowe PA, et al. Polymorphisms in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 1995 ; 345: 1540-1542.
15. Schmidt S., Stier E., Hartung R., et al. No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis 1995 ; 26: 727-731.
16. Yoshida H., Mitarai T., Kawamura T., et al. Role of the deletion of polymorphism of the angiotensin-converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995 ; 96: 2162-2169.
17. Yorioka T., Suehiro T., Yasuoka N., Hashimoto K. and Kawada M. Polymorphism of the angiotensin-converting enzyme gene and clinical aspects of IgA nephropathy. Clin Nephrol 1995 ; 44: 80-85.
18. Pei Y., Scholey J., Thai K., Suzuki M. and Cattran D. Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients. J Clin Invest 1997 ; 100: 814-820. (Pubitemid 27371699)
19. Liu ZH, Chen ZH, Hu WX, et al. Distribution of angiotensin-converting enzyme and angiotensin II receptor gene polymorphism in IgA nephropathy patients. Chin J Med Genet 14: 180-182 [In Chinese].
20. Burg M., Menne J., Ostendorf T., Kliem V. and Floege J. Gene polymorphisms of angiotensin-converting enzyme and endothelial nitric oxide synthase in patients with primary glomerulonephritis. Clin Nephrol 1997 ; 48: 205-211. (Pubitemid 27462632)
21. Tanaka R., Iijima K., Murakami R. et al. ACE gene polymorphism in childhood IgA nephropathy: association with clinicopathologic findings. Am J Kidney Dis 1998 ; 31: 774-779. (Pubitemid 28234628)
22. Stratta P., Canavese C., Ciccone G. et al. Angiotensin I-converting enzyme genotype significantly affects progression of IgA glomerulonephritis in an italian population. Am J Kidney Dis 1999 ; 33: 1071-1079. (Pubitemid 29252677)
23. Asano T., Tatsuma N., Yoshida J. et al. Association of angiotensin-converting enzyme gene polymorphism and renal pathology in Japanese children with IgA nephropathy. Clin Nephrol 1999 ; 51: 335-340. (Pubitemid 29261692)
24. Zheng X., Zhang YK, Li XY, Zhu SL, Bai QF and E J Study on the correlation between angiotensin-converting enzyme gene polymorphism and IgA nephropathy. Chin J Nephrol 1999 ; 15: 379-380 [In Chinese].
25. Frimat L., Philippe C., Maghakian MN, et al. Polymorphism of angiotensin-converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy: IGARAS - a study of 274 men. J Am Soc Nephrol 2000 ; 11: 2062-2067.
26. Maruyama K., Yoshida M., Nishio H., et al. Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr Nephrol 2001 ; 16: 350-355. (Pubitemid 32366670)
27. Schena FP, D'Altri C., Cerullo G., Manno C. and Gesualdo L. ACE gene polymorphism and IgA nephropathy: an ethnically homogeneous study and a meta-analysis. Kidney Int 2001 ; 60: 732-740. (Pubitemid 32678917)
28. Drouet M., Aupetit C., Denizot Y., et al. Analysis of three genetic markers in IgA nephropathy patients from a single region. Clin Nephrol 2002 ; 57: 253-260. (Pubitemid 34296386)
29. Santos NM, Ault BH, Gharavi AG, et al. Angiotensin-converting enzyme genotype and outcome in pediatric IgA nephropathy. Pediatr Nephrol 2002 ; 17: 496-502. (Pubitemid 36097311)
30. Lau YK, Woo KT, Choong HL, et al. ACE gene polymorphism and disease progression of IgA nephropathy in Asians in Singapore. Nephron 2002 ; 91: 499-503. (Pubitemid 34765253)
31. Liao YH, Li W., Guo Y., Chen YM and Zhang H. Analysis of clinicopathological characteristics of IgA nephropathy and ACE gene polymorphism in Guangxi Han population. J Guangxi Med Uni 2003 ; 20: 689-690. [In Chinese].
32. Woo KT, Lau YK, Choong LH, et al. Polymorphism of renin-angiotensin system genes in IgA nephropathy. Nephrology (Carlton) 2004 ; 9: 304-309. (Pubitemid 39576933)
33. Li R., Zhong N., Kang L., Xia T. and Su RS Relationship between renin-angiotensin system gene polymorphism and IgA nephropathy. Clin Focus 2007 ; 22: 685-688 [In Chinese].
34. Narita I., Goto S., Saito N., et al. Renoprotective efficacy of renin-angiotensin inhibitors in IgA nephropathy is influenced by ACE A2350G polymorphism. J Med Genet 2003 ; 40: 130.
35. Woo KT, Lau YK, Zhao Y., et al. Disease progression, response to ACEI/ATRA therapy and influence of ACE gene in IgA nephritis. Cell Mol Immunol 2007 ; 4: 227-232.
36. Woo KT, Lau YK, Chan CM and Wong KS Angiotensin-converting enzyme inhibitor versus angiotensin 2 receptor antagonist therapy and the influence of angiotensin-converting enzyme gene polymorphism in IgA nephritis. Ann Acad Med Singapore 2008 ; 37: 372-376.
37. Lau YK, Woo KT, Choong HL, et al. Renin-angiotensin system gene polymorphisms: its impact on IgAN and its progression to end-stage renal failure among Chinese in Singapore. Nephron Physiol 2004 ; 97: 1-8.
38. Ringrose TR, Thomas T. and Wilkinson R. ACE genotype and progression of IgA nephropathy. Lancet 1995 ; 346: 570-571.
39. Ong-Ajyooth S., Ong-Ajyooth L., Limmongkon A., et al. The renin-angiotensin system gene polymorphisms and clinicopathological correlations in IgA nephropathy. J Med Assoc Thai 1999 ; 82: 681-689.
40. Suzuki S., Suzuki Y., Kobayashi Y., et al. Insertion/deletion polymorphism in ACE gene is not associated with renal progression in Japanese patients with IgA nephropathy. Am J Kidney Dis 2000 ; 35: 896-903. (Pubitemid 30238203)
41. Chacko B., Raghuraman S., Neelakantan N., John GT and Jacob CK Impact of ACE gene polymorphisms on the progression of IgA nephropathy in India. Ren Fail 2007 ; 29: 647-648. (Pubitemid 47123813)
42. Syrjanen J., Huang XH, Mustonen J., et al. Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy. Nephron 2000 ; 86: 115-121.
43. McKenzie CA, Abecasis GR, Keavney B., et al. Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet 2001 ; 10: 1077-1084. (Pubitemid 32447785)
44. Yong D., Qing WQ, Hua L., et al. Association of angiotensin I-converting enzyme gene insertion/deletion polymorphism and IgA nephropathy: a meta-analysis. Am J Nephrol 2006 ; 26: 511-518. (Pubitemid 44971744)